Drug Master Files for: BELINOSTAT
✉ Email this page to a colleague
BELINOSTAT Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
26926 | A | II | 9/27/2013 | SPECTRUM PHARMACEUTICALS INC | BELINOSTAT DRUG SUBSTANCE |
31134 | A | II | 12/30/2016 | TIANJIN WEIJIE PHARMACEUTICAL CO LTD | BELINOSTAT |
32260 | A | II | 1/5/2018 | FRESENIUS KABI ONCOLOGY LTD | BELINOSTAT |
32405 | A | II | 4/11/2018 | BIOPHORE INDIA PHARMACEUTICALS PVT LTD | BELINOSTAT |
32660 | A | II | 3/29/2018 | MSN LABORATORIES PRIVATE LTD | BELINOSTAT |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information